×

FORMULATIONS FOR TREATING OCULAR DISEASES AND CONDITIONS

  • US 20090074786A1
  • Filed: 08/18/2008
  • Published: 03/19/2009
  • Est. Priority Date: 02/09/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating macular edema in a human subject by repeated administration of rapamycin, the method comprising:

  • administering two or more doses of a rapamycin formulation to an eye of the human subject, wherein the period between consecutive doses is at least 8 weeks, and the cumulative amount of rapamycin in the two or more doses is effective to treat macular edema in the human subject for an extended period of at least 16 weeks.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×